TROY EDWARD WILSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TROY EDWARD WILSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TROY EDWARD WILSON. TROY EDWARD WILSON is Director in PUMA BIOTECHNOLOGY, INC. ($PBYI) and President and CEO in Kura Oncology, Inc. ($KURA) and Director in Zosano Pharma Corp ($ZSAN) and Director in Avidity Biosciences, Inc. ($RNA).
Latest Insider Trading Transactions of TROY EDWARD WILSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RNA, KURA, PBYI, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 27,858 | 0 | 28,208 | 350 to 28.2 K (+7,959.43 %) |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 32.80 | 366,500 | 12,021,200 | 366,500 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | J | 0.00 | 175,000 | 0 | 1,620,017 | 1.8 M to 1.6 M (-9.75 %) |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Buy | J | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Sell | J | 0.00 | 100,000 | 0 | 89,618 | 189.6 K to 89.6 K (-52.74 %) |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Buy | J | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Sell | J | 0.00 | 100,000 | 0 | 89,618 | 189.6 K to 89.6 K (-52.74 %) |
| Dec 02 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 11,855 | 72,908 | 90,210 | |
| Dec 02 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 11,855 | 72,908 | 39,951 | 28.1 K to 40 K (+42.19 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 17,926 | 110,245 | 157,021 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.82 | 98,490 | 2,838,876 | 206,736 | 305.2 K to 206.7 K (-32.27 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 485 | 13,580 | 305,226 | 305.7 K to 305.2 K (-0.16 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 17,926 | 501,928 | 28,096 | 46 K to 28.1 K (-38.95 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 17,926 | 110,245 | 46,022 | 28.1 K to 46 K (+63.80 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 37,030 | 227,735 | 174,947 | |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 37,030 | 1,036,840 | 28,096 | 65.1 K to 28.1 K (-56.86 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 37,030 | 227,735 | 65,126 | 28.1 K to 65.1 K (+131.80 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 1,025 | 28,700 | 305,711 | 306.7 K to 305.7 K (-0.33 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 26.00 | 50,000 | 1,300,000 | 306,736 | 356.7 K to 306.7 K (-14.02 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 215 | 1,032 | 6,945 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 22,838 | 140,454 | 211,977 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 6,568 | 31,526 | 7,160 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.37 | 23,053 | 515,788 | 28,096 | 51.1 K to 28.1 K (-45.07 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 215 | 1,032 | 51,149 | 50.9 K to 51.1 K (+0.42 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 22,838 | 140,454 | 50,934 | 28.1 K to 50.9 K (+81.29 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.04 | 6,568 | 144,770 | 28,096 | 34.7 K to 28.1 K (-18.95 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 6,568 | 31,526 | 34,664 | 28.1 K to 34.7 K (+23.38 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 11,913 | 57,182 | 13,728 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 521 | 2,501 | 25,641 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 12,901 | 61,925 | 26,162 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.09 | 11,913 | 263,196 | 28,096 | 40 K to 28.1 K (-29.78 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 11,913 | 57,182 | 40,009 | 28.1 K to 40 K (+42.40 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 521 | 11,462 | 28,096 | 28.6 K to 28.1 K (-1.82 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 521 | 2,501 | 28,617 | 28.1 K to 28.6 K (+1.85 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 12,901 | 283,868 | 28,096 | 41 K to 28.1 K (-31.47 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 12,901 | 61,925 | 40,997 | 28.1 K to 41 K (+45.92 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 50,000 | 1,100,000 | 356,736 | 406.7 K to 356.7 K (-12.29 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Gift | G | 0.00 | 26,041 | 0 | 1,795,017 | 1.8 M to 1.8 M (+1.47 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Gift | G | 0.00 | 26,041 | 0 | 28,096 | 54.1 K to 28.1 K (-48.10 %) |
| Jun 16 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Option Exercise | C | 0.00 | 108,504 | 0 | 0 | |
| Jun 16 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Option Exercise | C | 0.00 | 35,374 | 0 | 0 | |
| Jun 16 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Option Exercise | C | 0.00 | 254,907 | 0 | 0 | |
| Jun 16 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Buy | C | 0.00 | 189,042 | 0 | 805,301 | 616.3 K to 805.3 K (+30.68 %) |
| Jun 15 2020 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Sell | S | 9.97 | 25,245 | 251,693 | 26,098 | 51.3 K to 26.1 K (-49.17 %) |
| Jun 11 2020 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 25,748 | 0 | 51,343 | 25.6 K to 51.3 K (+100.60 %) |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 26,911 | 129,173 | 39,063 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 1,185 | 7,288 | 234,815 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 26,911 | 129,173 | 54,137 | 27.2 K to 54.1 K (+98.84 %) |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 1,185 | 7,288 | 27,226 | 26 K to 27.2 K (+4.55 %) |
| Feb 03 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 11.86 | 393,950 | 4,672,247 | 393,950 | |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | WILSON TROY EDWARD | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Jun 12 2019 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 19,423 | 0 | 25,595 | 6.2 K to 25.6 K (+314.70 %) |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 15.47 | 220,000 | 3,403,400 | 220,000 | |
| Nov 09 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 26,041 | 124,997 | 65,974 | |
| Nov 09 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 26,041 | 124,997 | 59,026 | 33 K to 59 K (+78.95 %) |
| Jun 14 2018 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 5,822 | 0 | 6,172 | 350 to 6.2 K (+1,663.43 %) |
| Jun 01 2018 | ZSAN | Zosano Pharma Corp | WILSON TROY EDWARD | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
| Mar 02 2018 | ZSAN | Zosano Pharma Corp | WILSON TROY EDWARD | Director | Option Exercise | A | 0.53 | 30,000 | 15,900 | 30,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 20.00 | 275,000 | 5,500,000 | 275,000 | |
| Aug 23 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 27,985 | 134,328 | 92,015 | |
| Aug 23 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 27,985 | 134,328 | 32,985 | 5 K to 33 K (+559.70 %) |
| Jun 14 2017 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 79.20 | 7,604 | 602,237 | 7,604 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 6.15 | 236,000 | 1,451,400 | 236,000 | |
| Nov 16 2016 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 40.10 | 10,000 | 401,000 | 10,000 | |
| Nov 04 2016 | ZSAN | Zosano Pharma Corp | WILSON TROY EDWARD | Director | Option Exercise | A | 0.58 | 20,000 | 11,500 | 20,000 | |
| Feb 02 2016 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 4.80 | 120,000 | 576,000 | 120,000 | |
| Dec 17 2015 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 75.37 | 10,000 | 753,700 | 10,000 | |
| Sep 10 2015 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 95.22 | 10,000 | 952,200 | 10,000 | |
| Apr 02 2015 | ZSAN | Zosano Pharma Corp | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Dec 16 2014 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 195.33 | 10,000 | 1,953,300 | 10,000 | |
| Dec 20 2013 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 100.30 | 10,000 | 1,003,000 | 10,000 | |
| Oct 21 2013 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Option Exercise | A | 44.96 | 40,000 | 1,798,400 | 40,000 |
Page: 1